TOGA Post ASCO Symposium: Thoracic Cancer Highlights and Satellite Symposium

PROGRAM *Chair: Dr Maggie Moore* 6:30 PM – 8:15 PM AEST
Time	Topic	Speaker
6:30 PM – 6:35 PM	Session Introduction	Dr Maggie Moore Medical Oncologist Alfred Hospital
6:35 PM – 7:00 PM	TBC	Prof Kenneth O’Byrne Medical Oncologist and Clinical Scientist Princess Alexandra Hospital (PAH) and the Queensland University of Technology (QUT)
7:00 PM – 7:25 PM	TBC	Dr Ben Kong Medical Oncologist and Senior Research Fellow Prince of Wales Hospital and University of New South Wales
7:25 PM – 7:45 PM	Poster Picks: What Caught Our Eye at ASCO	A/Prof Malinda Itchins Medical Oncologist Royal North Shore Hospital, Chris O'Brien Lifehouse, and University of Sydney
7:45 PM – 8:10 PM	Panel Discussion	All Speakers
8:10 PM – 8:15 PM	Closing	Dr Maggie Moore

First Name

Last Name

Position

Organisation

Mobile

State

Country (if outside Australia)

Zip Code

Zip

Specialty/Discipline

If 'Other', please specify:

How did you hear about the event?

If 'Other', please specify:

Chair:

Dr Laird Cameron

Medical Oncologist, Te Puriri o Te Ora, Te Whatu Ora Te Toka Tumai Auckland

Dr Laird Cameron is a Medical Oncologist specialising in thoracic malignancies.

Laird completed a clinical fellowship in lung and head & neck malignancies at the Peter MacCallum Cancer Centre in Melbourne, Australia in 2016. He then returned to New Zealand and has been caring for patients with thoracic cancers in Auckland at Te Puriri o Te Ora, Auckland Hospital and Canopy Cancer Care since 2016. He is the current New Zealand representative on the TOGA scientific committee, past chair and founding member of NZ Lung Oncology Special Interest Group, current president of the New Zealand Society for Oncology and senior lecturer in the Department of Oncology at the University of Auckland. His research interests include lung cancer, equity and precision oncology.

Presenters:

	Dr Alex Davis Medical Oncologist, Northern Sydney Cancer Centre Dr Alex Davis is a medical oncologist with an interest in thoracic malignancies. His focus includes biomarker directed therapy, personalised medicine and patient centred decision making. He is a strong believer in clinical trials improving patient outcomes and is an active participant in several industry and TOGA led clinical trials. He is currently enrolled in a PhD at the University looking at KRAS mutant lung cancer and how co-mutations mediate clinical outcomes to immunotherapy and KRAS directed therapy.
	Dr Malinda Itchins Medical Oncologist, Royal North Shore Hospital and Chris O'Brien Lifehouse Dr Malinda Itchins BMedSci, MBBS(Hons1), FRACP, PhD, is a thoracic medical oncologist at Royal North Shore Hospital, and Chris O'Brien Lifehouse, Sydney. She is a senior clinical lecturer with the University of Sydney and Board Director with the Clinical Oncology Society of Australia (COSA). Malinda is Co-Chair of the Advanced NSCLC Group on the Scientific Committee of the Thoracic Oncology Group of Australasia (TOGA), and passionate trialist, researcher and advocate for improving care for all people affected by lung cancer.
	A/Prof Rachel Roberts-Thomson Medical Oncologist, The Queen Elizabeth Hospital and Cancer Care Adelaide Rachel is a Medical Oncologist in Adelaide, South Australia with a strong interest in treating patients with thoracic malignancies as well as melanoma. She enjoys being a Principal Investigator on clinical trials, clinical research projects as well as supervising and teaching. Her focus has been on immuno-therapeutics and targeted therapies with the excitement that exists in the field.
	Dr Lavinia Tan Medical Oncologist, Peter MacCallum Cancer Centre Dr Lavinia Tan is a Medical Oncologist with a sub-speciality interest in treating patients with lung cancer. She completed a clinical fellowship focusing on thoracic malignancies at the Peter MacCallum Cancer Centre and a laboratory-based PhD in the Molecular Biomarkers and Translational Genomics Laboratory exploring the utility of circulating tumour DNA to guide precision medicine in solid malignancies. Lavinia’s main research interests focus on understanding and developing novel strategies to overcome resistance to targeted therapies in oncogene driven lung cancers.

You need to enable JavaScript to access this site.

Follow these instructions on how to enable JavaScript.

Internet Explorer

Select Tools from the top menu
Choose Internet Options
Click on the Security tab
Click on Custom Level
Scroll down until you see the section labelled Scripting
Under Active Scripting, select Enable and click OK

Google Chrome

Select the menu icon on the browser toolbar
Select Settings
Click the Show advanced settings... link then Content Settings in the Privacy section
Select Allow all sites to run JavaScript (recommended) and click Done

Safari (Mac)

Select Safari from the top menu
Choose Preferences
Choose Security
Select the checkbox next to Enable JavaScript

TOGA Post ASCO Symposium: Thoracic Cancer Highlights and Satellite Symposium

TOGA Post ASCO Symposium:

Thoracic Cancer Highlights and Satellite Symposium

Dr Laird Cameron

Dr Alex Davis

Dr Malinda Itchins

A/Prof Rachel Roberts-Thomson

Dr Lavinia Tan